Publications by authors named "Hiroyuki Hanai"

Claim this Profile
V
Vedolizumab-steroid combination therapy improves long-term prognosis in patients with ulcerative colitis.
Yosuke Yamada, Natsuki Ishida, Tomohiro Takebe, Kenichi Takahashi, Yusuke Asai, Hiroyuki Hanai

BMC Gastroenterol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Utility of abdominal ultrasonography in the management of ulcerative colitis:proposal of a new scoring system].
Shinsuke Sato, Kentaro Ikeya, Ryosuke Takano, Ai Matsuura, Yuji Ota, Hiroyuki Hanai

Nihon Shokakibyo Gakkai Zasshi· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DEVELOPMENT OF A ROBOT FOR THE MEASUREMENT OF RADIOACTIVE CONTAMINATION AND FERTILITY OF THE SOIL IN FARMLAND.
Minoru Tanigaki, Yoshio Inoue, Sadao Momota, Takashi Saito, Tomoaki Nemoto, Hiroyuki Hanai

Radiat Prot Dosimetry· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crohn's Disease and Early Exposure to Thiopurines are Independent Risk Factors for Mosaic Chromosomal Alterations in Patients with Inflammatory Bowel Diseases.
Yoichi Kakuta, Hideya Iwaki, Junji Umeno, Yosuke Kawai, Masahiro Kawahara, Hiroyuki Hanai

J Crohns Colitis· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Background of Mesalamine-induced Fever and Diarrhea in Japanese Patients with Inflammatory Bowel Disease.
Kaoru Suzuki, Yoichi Kakuta, Takeo Naito, Tetsuya Takagawa, Hiroyuki Hanai

Inflamm Bowel Dis· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease.
Masaichi Kato, Ken Sugimoto, Kentaro Ikeya, Ryosuke Takano, Ai Matsuura, Hiroyuki Hanai

PLoS One· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly Bioavailable Curcumin Derivative Ameliorates Crohn's Disease Symptoms: A Randomized, Double-Blind, Multicenter Study.
Ken Sugimoto, Kentaro Ikeya, Shigeki Bamba, Akira Andoh, Hiroshi Yamasaki, Hiroyuki Hanai

J Crohns Colitis· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Follow-Up of Targeted Biopsy Yield (LOFTY Study) in Ulcerative Colitis Surveillance Colonoscopy.
Keisuke Hata, Soichiro Ishihara, Yoichi Ajioka, Keiichi Mitsuyama, Kenji Watanabe, Hiroyuki Hanai

J Clin Med· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of apheresis as maintenance therapy for patients with ulcerative colitis in an open-label prospective multicenter randomised controlled trial.
Makoto Naganuma, Yoko Yokoyama, Satoshi Motoya, Kenji Watanabe, Koji Sawada, Hiroyuki Hanai

J Gastroenterol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Long-Term Efficacy and Safety of Adalimumab in Patients with Ulcerative Colitis: Results from a 6-Year Real-World Clinical Practice.
Ken Sugimoto, Kentaro Ikeya, Masaichi Kato, Ai Matsuura, Fumitoshi Watanabe, Hiroyuki Hanai

Dig Dis· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitis.
Takayuki Yamamoto, Takayuki Iida, Kentaro Ikeya, Masaichi Kato, Ai Matsuura, Hiroyuki Hanai

Clin Transl Gastroenterol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitis.
Takayuki Yamamoto, Takayuki Iida, Kentaro Ikeya, Masaichi Kato, Ai Matsuura, Hiroyuki Hanai

Clin Transl Gastroenterol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study.
Yoichi Kakuta, Yosuke Kawai, Daisuke Okamoto, Tetsuya Takagawa, Kentaro Ikeya, Hiroyuki Hanai

J Gastroenterol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitis.
Takayuki Yamamoto, Takayuki Iida, Kentaro Ikeya, Masaichi Kato, Ai Matsuura, Hiroyuki Hanai

Clin Transl Gastroenterol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adsorptive Depletion of Myeloid Lineage Leucocytes as Remission Induction Therapy in Patients with Ulcerative Colitis after Failure of First-Line Medications: Results from a Three-Year Real World, Clinical Practice.
Takayuki Iida, Kentaro Ikeya, Masaichi Kato, Jinro Abe, Masayoshi Yamamoto, Hiroyuki Hanai

Digestion· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis.
Yasuo Suzuki, Satoshi Motoya, Hiroyuki Hanai, Toshifumi Hibi, Shiro Nakamura

J Gastroenterol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis.
Yasuo Suzuki, Satoshi Motoya, Hiroyuki Hanai, Toshifumi Hibi, Shiro Nakamura

J Gastroenterol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real life results in using 5-ASA for maintaining mild to moderate UC patients in Japan, a multi-center study, OPTIMUM Study.
Masakazu Nagahori, Shuji Kochi, Hiroyuki Hanai, Takayuki Yamamoto, Shiro Nakamura

BMC Gastroenterol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of CT Colonography for Detection of Polypoid and Nonpolypoid Neoplasia by Gastroenterologists and Radiologists: A Nationwide Multicenter Study in Japan.
Koichi Nagata, Shungo Endo, Tetsuro Honda, Takaaki Yasuda, Michiaki Hirayama, Hiroyuki Hanai

Am J Gastroenterol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Targeted vs Random Biopsies for Surveillance of Ulcerative Colitis-Associated Colorectal Cancer.
Toshiaki Watanabe, Yoichi Ajioka, Keiichi Mitsuyama, Kenji Watanabe, Hiroyuki Hanai

Gastroenterology· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Ulcerative Colitis Endoscopic Index of Severity More Accurately Reflects Clinical Outcomes and Long-term Prognosis than the Mayo Endoscopic Score.
Kentaro Ikeya, Hiroyuki Hanai, Ken Sugimoto, Satoshi Osawa, Shinsuke Kawasaki

J Crohns Colitis· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Increased Serum N-Terminal Telopeptide of Type I Collagen, a Biochemical Marker of Increased Bone Resorption, Is Associated with Infliximab Therapy in Patients with Crohn's Disease.
Ken Sugimoto, Kentaro Ikeya, Takayuki Iida, Shinsuke Kawasaki, Osamu Arai, Hiroyuki Hanai

Dig Dis Sci· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enteral nutrition for maintaining remission in patients with quiescent Crohn's disease: current status and future perspectives.
Maki Nakahigashi, Takayuki Yamamoto, Rodolfo Sacco, Hiroyuki Hanai, Fumio Kobayashi

Int J Colorectal Dis· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label prospective randomized multicenter study of intensive versus weekly granulocyte and monocyte apheresis in active crohn's disease.
Naoki Yoshimura, Yoko Yokoyama, Katsuyoshi Matsuoka, Hiroki Takahashi, Ryuichi Iwakiri, Hiroyuki Hanai

BMC Gastroenterol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tacrolimus for remission induction in ulcerative colitis: Mayo endoscopic subscore 0 and 1 predict long-term prognosis.
Kentaro Ikeya, Ken Sugimoto, Shinsuke Kawasaki, Takayuki Iida, Yasuhiko Maruyama, Hiroyuki Hanai

Dig Liver Dis· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis